API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

3-Quinuclidinone Hydrochloride: Key Intermediate and Biocatalytic Reduction

3-Quinuclidinone hydrochloride is a vital pharmaceutical intermediate and two new NADH-dependent reductases can stereoselectively produce (R)-3-quinuclidinol.

Apr 30,2026  API

Bioactivities and Inhibitory Mechanisms of Staurosporine

Staurosporine suppresses nasal polyp growth via regulating TGF-β1/Smad2 pathway, while its low selectivity spurs derivative development for safer use.

Apr 30,2026  API

Clenbuterol: Metabolic Effects and Performance-Related Actions

Clenbuterol is a β2-AR which increases lean mass but reduces cardiorespiratory fitness, supporting its anti-diabetic potential and sports prohibition.

Apr 30,2026  API

Clinical Applications and Safety Profiles of Edoxaban

Edoxaban is an oral direct factor Xa anticoagulant used for stroke and thromboembolism prevention which shows mild transient liver enzyme elevations.

Apr 29,2026  API

Preparation method and Complexation of 4-tert-Butylbenzoic acid

4-tert-Butylbenzoic acid exhibits significant alkalinity and is mainly used as a basic raw material in fine chemical production.

Apr 29,2026  API

4-(Trifluoromethoxy)nitrobenzene: Synthesis and Structural Properties

4-(Trifluoromethoxy)nitrobenzene is an intermediate for medicines and pesticides and it can be synthesized efficiently via green microchannel reaction.

Apr 28,2026  API

Strontium Titanate: Structure and Multifunctional Applications

Strontium titanate supports lattice dynamic modeling, forms bioactive PVA nanocomposites, and exhibits rich photoinduced electronic and ionic effects.

Apr 27,2026  API

Indications and Biological activity of Enalapril maleate

Enalapril is a pro-drug used in medicine to treat renin-dependent hypertension. In the body, the pro-drug is hydrolysed by esterases to yield enalaprilate.

Apr 26,2026  API

Tetradecyltrimethylammonium Bromide Properties

Tetradecyltrimethylammonium bromide owns amphiphilic structure and excellent surface activity and it inhibits protein fibrillation via polar interaction.

Apr 25,2026  API

4-Chloro-7-azaindole: Synthetic Intermediate for Drug Research

4-Chloro-7-azaindole is a key pharmaceutical and organic intermediate synthesized and it serves for preparing JAK inhibitors and heterocyclic derivatives.

Apr 25,2026  API
Prev12345678910...Next>  Go to Page